Monoclonal antibody treatment for COVID-19 | Daily Current Affairs 2021
onwin giriş

Monoclonal antibody treatment for COVID-19

Posted by
Subscribe for News Feed
Monoclonal Antibodies

Monoclonal antibody treatment has emerged as a relatively effective and safer alternative in treating COVID-19 patients.

Key Points:

  • As per the statement of the doctors, as with any other drug, timing is very important for the administration of the therapy that’s touted as a game-changer.
  • Monoclonal antibodies have previously been used to treat infections such as Ebola and HIV.
  • The therapy is now said to help avoid hospitalization in high-risk groups, progression to severe disease, and to reduce the usage of steroids.
  • However, doctors claim that though the method does not cure the infection. The treatment helps in preventing the development of Covid-19 severity among mild to moderately infected patients with severe comorbidities if administered within seven days of the infection.

Immune response of antibodies in human beings:

  • Antibodies produced naturally in bodies fight against diseases.
  • The body’s immune system generates antibodies as a defense mechanism against unfamiliar molecules from bacteria and viruses, termed antigens.
  • Antibodies bind to antigens and kill the invading pathogen.

Monoclonal antibody treatment:

  • Monoclonal antibodies too, work similarly as the naturally produced antibodies in a human body, but these are made artificially in a laboratory that helps in defending against the disease.
  • The Monoclonal antibodies help in reducing the symptoms and disease progression.
  • These antibodies have previously been used to treat viral infections such as Ebola and HIV.
  • Two of the Monoclonal antibodies being used in India include the REGCov2 (Casirivimab and Imdevimab).
  • In these drugs, antibodies for COVID target specific proteins and destroy them before they initiate inflammation.

What are Monoclonal antibodies?

  • Monoclonal antibodies are identical copies of an antibody that targets one specific antigen.
  • Scientists can make monoclonal antibodies by exposing white blood cells to a particular antigen.
  • Each monoclonal antibody is specific to its matching antigen.
  • Scientists select a single white blood cell or clone and use this as the basis to produce many identical cells, making many identical copies of the monoclonal antibody.

Subscribe for News Feed